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Abstract
Background: Th1/Th2 cell balance is thought to be shifted toward a Th2-type immune response
not only by malignancy but also by surgical stress. The aim of this study was to estimate
perioperative immune responses with respect to the Th1/Th2 balance in patients with
gastrointestinal cancer.
Methods: Ninety-four patients who underwent abdominal surgeries were divided into three
groups: gastric resection (n = 40), colorectal resection (n = 34) and hepatic resection (n = 20).
Twelve patients undergoing laparoscopic cholecystectomy and 20 healthy subjects were served as
control groups. Intracellular cytokine staining in CD4+ T lymphocytes was identified to
characterize Th1/Th2 balance. Th1/Th2 balance was evaluated before operation and until
postoperative days (POD) 14.
Results:  The preoperative Th1/Th2 ratio was significantly lower in patients with malignancy
compared with control. The Th1/Th2 ratio of patients in all groups decreased significantly
postoperatively. Th1/Th2 balance on POD 2 in patients with malignancy was significantly decreased
compared to patients with laparoscopic cholecystectomy, but there were no significant differences
among the four groups on POD 14.
Conclusion:  Patients with malignancy showed an abnormal perioperative Th1/Th2 balance
suggesting predominance of a type-2 immune response. Major abdominal surgeries induce a marked
shift in Th1/Th2 balance toward Th2 in the early postoperative stage.
Background
Immunity to malignancy is influenced not only by CD8+
T cells, but also by the function of CD4+ T helper (Th)
lymphocytes, which are important in cell-mediated and
humoral immunity [1]. Since the initial description by
Mosmann et al. [2] of subclasses of CD4+ helper T cells
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(Th) that differ in cytokine secretion, immune responses
have been classified into type 1 responses that provide
cell-mediated immunity, and type 2 responses that sup-
port B cell functions and the humoral immune response.
Exposure of naïve Th cells to certain antigens and
cytokines causes CD4+ T cells to assume one of these two
distinct phenotypes. Th1 cells produce predominantly
interferon-γ (IFN-γ) and interleukin-2 (IL-2), whereas Th2
cells secrete predominantly IL-4, IL-6 and IL-10 [3].
Several studies have shown reduced secretion of Th1 in
bulk cultures of peripheral blood mononuclear cells
(PBMC) from advanced cancer patients [4,5]. However, a
few studies of Th1/Th2 balance have been performed on
large numbers of patients with abdominal cancer [6,7].
The first objective of the present study was to estimate
roles of these two CD4+ subsets in anti-tumor immunity.
It has been reported that the Th1/Th2 cell balance is
shifted toward a Th2-type immune response not only by
malignancy but also by surgical stress [8-10]. Decker et al.
[11] have shown that surgical stress induces a shift in the
Th1/Th2 cell balance, suggesting a down-regulation of
cell-mediated and up-regulation of antibody-mediated
immunity commensurate with surgical trauma. However,
the extent to which surgical stress influences the Th1/Th2
balance is unknown. The second objective of this study
was to assess changes in the Th1/Th2 balance in patients
undergoing surgical stress, and to clarify whether a shift in
the Th1/Th2 balance can be used to facilitate comparisons
of different abdominal surgeries.
Patients and methods
Ninety-four consecutive patients (55 males, 39 females;
mean age of 66 ± 11 years) underwent abdominal surgery
for the first time at our clinic between April 2000 and
April 2002. The experimental protocol was approved by
the Research Committee of National Kochi Hospital. All
patients were informed of the nature and risk of this
study, and written informed consent was obtained. The
criteria for inclusion were major surgical tumor resection
(digestive tract or liver cancers) and expected duration of
operation of 3 hours or more. The patients were divided
into the following three groups according to surgical pro-
cedure. Forty gastric resections for gastric cancer (24
males, 16 females; mean age of 65 ± 13 years), 34 colorec-
tal resections for colorectal cancer (19 males, 15 females;
mean age of 66 ± 15 years) and 20 hepatic resection for
liver cancer (8 hepatocellular carcinomas, 5 liver metas-
tases and 7 biliary tract carcinomas) (12 males, 8 females;
mean age of 66 ± 8 years) were performed, respectively
(Table 1).
Twelve laparoscopic cholecystectomy (LC) (6 males, 6
females; mean age of 58 ± 14 years) and 20 healthy sub-
jects (10 males and 10 females; mean age of 60 ± 12 years)
served as the control groups. The patients with malig-
nancy were divided into four groups corresponding to the
four stages of disease (stage I (n = 28), stage II (n = 36),
stage III (n = 22), stage IV (n = 8), respectively) by UICC
classification. The duration of operation and operative
blood loss for each procedure were 223 ± 55 min and 267
± 212 ml for gastric resection, 220 ± 71 min and 325 ± 336
ml for colorectal resection, 365 ± 85 min and 761 ± 759
ml for hepatic resection and 116 ± 45 min and 46 ± 80 ml
for LC, respectively. Ten patients (5 [25%] hepatic resec-
tions, 2 [5%] gastric resections, 3 [9%] colorectal resec-
tions) developed postoperative complications (4
abdominal abscesses, 4 leakages and 2 pneumonia).
These major infectious complications typically occurred
on POD 4 or 5 (range 3–7 days). All patients had a rela-
tively uneventful recovery within POD 30 (range 15–25
days). No patients with laparoscopic cholecystectomy
developed postoperative complications.
Flow cytometric analysis of intracellular IFN-γ and IL-4
Blood sampling was performed before surgery, and on
POD 2 and 14. CBC and leukocyte differential analyses
were performed with an automated cell counter (Sysmex
SE-9000, Kobe, Japan). The proportion of CD4+ lym-
phocytes producing IFN-γ, IL-2, IL-4 and IL-6 were meas-
ured by flow cytometry (Beckman Coulter, Inc., Florida,
Miami, USA) as described by Openshaw et al, [12].
Briefly, 1 ml of each blood sample was treated immedi-
ately with 10 ng/ml of Brefeldin A (Sigma B7651), kept at
ambient temperature, and prepared within 2 hours.
Peripheral blood lymphocytes were harvested, washed,
and resuspended at 105–106/ml and stimulated with PMA
Table 1: Details of the procedures
Disease Case Male:female Surgical procedure Operating time (min) Intraoperative bleeding (ml)
Gastric cancer 40 24:16 Gastric resection (40) 223 ± 55 267 ± 212
Colon cancer 34 19:15 Intestinal resection (34) 220 ± 71 325 ± 336
Hepatobiliary cancer 20 12:8 Partial resection (8) 365 ± 85 761 ± 759
HCC 8 12:8 Subsegmental resection (2) 365 ± 85 761 ± 759
Liver metastasis 5 12:8 Segmental resection (3) 365 ± 85 761 ± 759
Ca of biliary tract 7 12:8 Lobectomy (7) 365 ± 85 761 ± 759
Cholelithiasis 12 6:6 Laparoscopic cholecystectomy (12) 116 ± 45 46 ± 180World Journal of Surgical Oncology 2009, 7:7 http://www.wjso.com/content/7/1/7
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50 ng/ml (Sigma P8139) plus ionomycin (Sigma 10634)
500 ng/ml. After a wash and 10-min incubation in PBS/
BSA/saponin, cells were incubated with anti-CD4 mono-
clonal Ab and anti-IFN-γ (DAKO, RG285, Denmark),
anti-IL-2 (DAKO, RG202), anti-IL-4 (DAKO, RG204) or
anti-IL-6 (DAKO, RG206) for 30 min before adding an
equal volume of 4% formaldehyde fixative. After washing
and incubating with PBS/BSA/saponin for 10 min, cells
were incubated with for 30 min, respectively. Results were
analyzed using the XL/XL-MCL system and were calcu-
lated as a ratio of the percent IFN-γ-producing (Th1) cells
to IL-4-producing (Th2) cells.
Statistical analysis
Values for results are presented as means ± SD. Student's t
test was used for comparison of continuous variables. Dif-
ferences between groups with respect to time were com-
pared using the analysis of variance (ANOVA) for
repeated measures. A p value of < 0.05 was considered sig-
nificant.
Results
The lymphocyte count in all patients decreased signifi-
cantly after surgery, reaching a nadir of almost one-third
of baseline on POD 2 (Fig. 1). There was no significant
difference in the lymphocyte count among the four
groups including the LC group before surgery. Patients
with hepatic resection presented with 531 ± 24 cells/μl on
POD 2, then rebounded by POD 14 to 1017 ± 494 cells/
μl. However, the lymphocyte count in patients with
hepatic resection was significantly lower than in those
with gastric and colorectal resection on POD 2 and 14.
The preoperative percentage of IL-4-producing T cells
from PBMC of patients with malignancy was significantly
higher than in the control groups, while patients who
underwent LC showed no significant differences from the
healthy controls. In contrast, the preoperative percentages
of IL-2, IFN-γ and IL-6-producing T cells in all patient
groups were similar to the healthy control group. There-
fore, the preoperative ratio of the percentage of IFN-g-pro-
Lymphocyte counts for patients Figure 1
Lymphocyte counts for patients. (Black squares – gastric resection (n = 40), black circles – colorectal resection (n = 34), 
black triangles – hepatic resection (n = 20), white squares – laparoscopic cholecystectomy(n = 12)). Lymphocyte count in all 
groups decreased significantly after surgery. The lymphocyte counts for patients with hepatic resection became significantly 
lower than those in the gastric and colorectal resection groups after surgery.World Journal of Surgical Oncology 2009, 7:7 http://www.wjso.com/content/7/1/7
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ducing T cells (Th1) to IL-4-producing T cells (Th2) was
significantly higher in healthy controls and patients who
underwent LC than in those who underwent operations
for malignancy, the means being 11.3 ± 4.3, 10.8 ± 5.6
and 6.8 ± 4.2 (p < 0.01), respectively. There were no sig-
nificant differences in the preoperative ratio of Th1 to Th2
among gastric, colorectal and hepatic resection groups,
the mean being 5.2 ± 3.6 in patients with gastric cancer,
7.2 ± 3.1 in those with colorectal cancer and 6.6 ± 4.0 in
those with hepatic cancer (Fig. 2). Preoperatively, malig-
nancy groups showed a significantly higher percentage of
T cells producing IL-4 than that of LC and healthy control
groups. Interestingly, no significant differences were
observed according to staging in patients with malignant
disease: 6.9 ± 3.5 in stage I, 6.5 ± 3.7 in stage II, 6.6 ± 3.1
in stage III, 5.5 ± 2.6 in stage IV.
Postoperatively, the ratio of Th1 to Th2 decreased in all
groups (4.5 ± 3.0 in malignancy groups, 6.7 ± 4.1 in LC
groups on POD 2) (Fig. 2). The ratio of Th1/2 in patients
with malignancy markedly decreased to 4.3 ± 2.1 in gas-
tric resection, 4.9 ± 2.6 in colorectal resection and 2.9 ±
1.6 in hepatic resection on POD 2, with significant differ-
ences (p < 0.05) compared to patients undergoing LC.
However, these ratios recovered to preoperative levels on
POD 14 in all groups. There were no significant differ-
ences in the percentage of CD4+IFN-γ+ T cells among all
groups prior to surgery (14.0 ± 8.5% in gastric resection,
13.6 ± 6.6% in colorectal resection, 16.3 ± 8.3% in hepatic
resection and 14.6 ± 15.6% in LC). Significant changes in
the postoperative percentage of CD4+IFNγ+ T cells were
not seen other than a reduction on POD 2 in the hepatic
resection group (11.7 ± 6.9%, P < 0.05) (Fig. 3). In con-
trast to CD4+IFNγ+ T cells frequencies, the percentage of
CD4+IL-4+ T cells in all groups significantly increased on
POD 2 (5.1 ± 2.7% in gastric resection, 4.5 ± 2.7% in
colorectal resection, 5.5 ± 2.8% in hepatic resection and
3.2 ± 3.0% in LC) compared with before surgery (4.1 ±
2.5% in gastric resection, 2.6 ± 1.5% in colorectal resec-
tion, 3.3 ± 2.6% in hepatic resection and 1.6 ± 1.3% in
LC) (Fig. 4).
There were no significant differences in the percentage of
CD4+IL-2+ T cells among all groups prior to surgery (17.2
± 16.6% in gastric resection, 12.7 ± 11.0% in colorectal
resection, 16.2 ± 12.7% in hepatic resection and 8.0 ±
5.8% in LC). No significant differences in the percentage
of CD4+IL-2+ T cells among all groups after surgery were
Changes in the Th1/2 ratio in surgical patients with respect to operative procedure Figure 2
Changes in the Th1/2 ratio in surgical patients with respect to operative procedure. (Black squares – gastric resec-
tion (n = 40), black circles – colorectal resection (n = 34), black triangles – hepatic resection (n = 20), white squares – laparo-
scopic cholecystectomy(n = 12)). The Th1/2 ratio in all groups decreased significantly on POD 2 and significant differences 
were noted between malignancy group and LC group. However, the ratio in all groups recovered to preoperative levels on 
POD 14.World Journal of Surgical Oncology 2009, 7:7 http://www.wjso.com/content/7/1/7
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found. On the other hand, there were also no significant
differences in the percentage of CD4+IL-6+ T cells among
all groups prior to surgery (39.2 ± 28.9% in gastric resec-
tion, 32.1 ± 23.3% in colorectal resection, 40.0 ± 24.9%
in hepatic resection and 30.3 ± 37.0% in LC), showing no
significant differences among all groups after surgery.
In the malignancy group there were no significant differ-
ences between patients with and without postoperative
complications prior to surgery and on POD 2 (4.6 ± 2.5 vs.
4.4 ± 3.2), but the Th1/2 ratio in 10 patients with postop-
erative complications was 3.5 ± 2.0 on POD 14, signifi-
cantly lower than in patients without postoperative
complications (7.2 ± 4.4, p < 0.05) (Fig. 5). The percent-
ages of CD4+IFN-γ+T cells in patients with postoperative
complications decreased significantly to 11.4 ± 6.1% on
POD 14 compared to patients without postoperative com-
plications (14.6 ± 6.6%). In contrast, the percentage of
CD4+ IL-4+ T cells in patients with and without complica-
tions on POD 2 exhibited the opposite trend (5.3 ± 1.5 vs.
4.3 ± 1.0%, for patients with and without complications,
respectively, p < 0.05).
Discussion
Some previous studies have shown that cell-mediated but
not humoral immunity is impaired in cancer patients
[13]. However, it has not been determined whether this
impairment is more generally associated with the pres-
ence tumors. Surprisingly, among patients with cancer in
the present study, there were no differences in the Th1/
Th2 ratio between the patients with early cancer and
advanced cancer. It therefore seems that, in advanced can-
cer patients, the shift towards Th2 might be due to altered
representation of subsets as well as a change in capacity of
cells to secrete cytokine. However, Pellegrini et al. [4]
reported that serum levels of IL-4 in patients with stage I
disease were significantly higher than control subjects and
positively correlated with disease stage. Therefore, they
also examined cytokine produced by tumor-draining lym-
phocytes from lymph nodes and reported that when
Perioperative changes of measurements of IFN-γ in surgical patients Figure 3
Perioperative changes of measurements of IFN-γ in surgical patients. (Black squares – gastric resection (n = 40), 
black circles – colorectal resection (n = 34), black triangles – hepatic resection (n = 20), white squares – laparoscopic cholecys-
tectomy(n = 12)). There were no significant differences in the percentage of CD4+ IFN-γ+T cells among all groups prior to 
surgery. Significant decrease, however, in the postoperative percentage of CD4+ IFN-γ+T cells were not seen other than the 
reduction on POD 2 in the hepatic resection group.World Journal of Surgical Oncology 2009, 7:7 http://www.wjso.com/content/7/1/7
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tumor cells infiltrate the lymph node, the generation of Th
cells in the lymph node environment is shifted towards a
Th2-type immune response. The ability of IL-4 to inhibit
IL-2 gene transcription has been confirmed by other
researchers [14,15], suggesting that the elevation of IL-4
production during an ongoing immune response to
tumor can down-regulate Th1 cytokine production.
Therefore, in gastrointestinal cancer patients, the initial
tumor establishment may arise from, or be accompanied
by, a reduced Th1/Th2.
Hensler et al. [16]reported that during the early postoper-
ative course, major surgery resulted in a severe defect of T
cells to proliferate and to secrete cytokines characteristic
of both Th1 and Th2 phenotypes. They also reported that
during the late postoperative course (day 5), production
of IL-2 and IFN-γ had increased, reaching levels similar to
those observed before surgery. O'Sullivan et al., [14] dem-
onstrated that peripheral blood mononuclear cells from
trauma patients examined 1 to 14 days after injury pro-
duced significantly less IFN-γ than those from healthy
control subjects, but production of IL-4 was increased.
With respect to lymphocyte numbers, we found that lym-
phocyte numbers were depressed on POD 2 after major
surgery, and recovered within the first postoperative week.
Both the reduction in lymphocyte numbers and their sub-
sequent recovery varied with the extent of surgical proce-
dure. Some studies have found decreases in both CD4+
and CD8+ lymphocytes following major surgery [17],
while other studies on gastric cancer patients revealed a
significant decrease in numbers of CD8+ but not CD4+
lymphocytes [18] although our study only investigated
bulk lymphocyte numbers.
The present findings showed that the Th1/Th2 balance in
the LC group as well as malignancy group decreased on
POD 2, but the decrease in the LC group was slight on
POD 2. The increase percentage of CD4+IL-4+ T cells in all
Perioperative changes of measurements of IL-4 in surgical patients Figure 4
Perioperative changes of measurements of IL-4 in surgical patients. (Black squares – gastric resection (n = 40), black 
circles – colorectal resection (n = 34), black triangles – hepatic resection (n = 20), white squares – laparoscopic cholecystec-
tomy(n = 12)). There were significant differences in the percentage of CD4+ IL-4+T cells between malignancy group and LC 
groups prior to surgery. The postoperative percentage of CD4+ IL-4+T cells in all groups significantly increased on POD 2 
compared with before operation.World Journal of Surgical Oncology 2009, 7:7 http://www.wjso.com/content/7/1/7
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groups resulted in the observed decrease in the Th1/Th2
ratios. Interestingly, there were no significant differences
on POD 14 among all groups corresponding with the
finding of O'Sullivan et al [14].
Two important questions remain to be answered; whether
a shift in the Th1/Th2 balance can be used to facilitate
comparisons of different surgical procedures, and the clin-
ical significance of the surgery-induced shift in the Th1/
Th2 balance. The present findings confirm the findings of
Decker et al., [10] who demonstrated that the Th1/Th2
balance illustrated by the IL-4/IFN-γ and CD23/HLA-DR
ratios was markedly different between LC and open chole-
cystectomy. It was shown that down-regulation of the Th1
immune response makes patients more susceptible to
infections with viruses and intracellular bacteria. How-
ever, no study has examined to what extent operative pro-
cedures in major abdominal surgeries influence the Th1/
Th2 balance. To our knowledge, the present study is one
of the first to provide information on the Th1/Th2 ratio
during the early and delayed period after different major
abdominal surgeries from a rather large patient sample.
The Th1/Th2 balance in patients undergoing hepatic
resection decreased significantly as compared with those
in gastric resection and colorectal resection on POD 2 but
a significant difference was not noted between the three
groups preoperatively or later in the postoperative course
(POD 14).
The present study also showed that a shift toward a Th2
immune response continued until POD 14 in patients
who developed postoperative complications. There was
no significant difference in the preoperative and POD 2
Th1/Th2 balance, regardless of the presence of postopera-
tive complications. The first clinical signs of major post-
operative complications were invariably preceded by a
significant decline in Th1/Th2 balance after major
abdominal surgeries. Therefore, these data support a caus-
ative relationship between the post-operative severity of
immunosuppressive sequelae and the patient's suscepti-
bility to infectious complications. However, it is difficult
to predict the occurrence of postoperative complications
Changes in Th1/Th2 ratio in surgical patients with malignancy from the viewpoint of postoperative complications Figure 5
Changes in Th1/Th2 ratio in surgical patients with malignancy from the viewpoint of postoperative complica-
tions. (Complication (-) n = 84, complication (+) n = 10) The patients with postoperative complications showed significantly 
lower Th1/2 ratios on POD 14 although there were no significant differences in the two groups before operation or on POD 
2.World Journal of Surgical Oncology 2009, 7:7 http://www.wjso.com/content/7/1/7
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from the ratio of the Th1/Th2 balance in patients prior to
operation [19,20]. Post-surgical immunosuppression may
be favored by the preoperative clinical-biological status of
patients and the extent of surgical trauma such as hormo-
nal changes evoked by stress, hemorrhage, transfusion
and duration of the operation. In the present study, the
patient's Th1/Th2 ratio before surgery or on POD 2 was
not an associated factor in predicting postoperative com-
plications, but the percentage of CD4+IL-4+ T cells in
patients with postoperative complications was signifi-
cantly higher than in patients without complications.
Therefore, the increased percentage of Th2 cells may pre-
dict the occurrence of postoperative complications. On
the other hand, van Sandick et al. [17], demonstrated that
preoperative IFN-γ production acted as an independent
predictive variable for the occurrence of postoperative
major infection. Davis et al. [20], recently reported on the
possible role of the IFN-γ receptor 1 gene in predicting
major infection after operations. As severe trauma such as
hepatic resection and occurrence of postoperative compli-
cations were associated with decreased numbers of IFN-γ-
producing T cells, a deficiency in the type 1 response may
play a key role in immune suppression of such patients, as
reported in this study [9,21].
Conclusion
The present study has demonstrated that the elevation of
Th2 subset in patients with stage I cancer as compared
with healthy subjects or patients with cholecystolithiasis
suggests that the tumor-bearing state may induce a switch
from a Th1-type to a Th2-type cytokine profile, although
further research is necessary. Although there is an increase
in the representation of Th2 cells among CD4+ peripheral
lymphocytes in patients with gastrointestinal cancer, there
is no corresponding decrease in the frequency of Th1 cells.
Impaired host immunity or excessive stress after major
surgery often increases susceptibility to infection. These
results suggest that the extent of postoperative immune
depression is related to the extent of surgical tissue resec-
tion. The determination of Th1/Th2 balance may be of
help in evaluating different surgical procedures and prop-
erly monitoring patients post-surgery.
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